• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection
  • News
  • Opinion
  • About
  • Glossary

About

Welcome to PharmacovigilanceAnalytics.com!

This site will provide you with the latest information on pharmacovigilance analytics (PV analytics), with emphasis on new technological advances related to big data analytics, artificial intelligence, cognitive computing, data mining, text and information mining, and visualization tools, among others, and how they integrate with drug safety and pharmacovigilance.

You will also find the latest news to keep you up-to-date in the field. A manually picked selection of content curated by ourselves, will also give you the most relevant information found in scientific journals and publications.

I’m allowing you to get in my own pharmacovigilance analytics workshop, where I apply all sorts of techniques to drug safety and pharmacovigilance data, with the aim of extracting the diamond, data normally hide, even though I will not work on data mining exclusively.

Our passion is to help providing knowledge discovery on the factors governing the association between the exposure to a medicinal product and its effects on the population

My name is Jose Rossello and I am passionate about learning, teaching, and sharing what I learn. My medical specialty is Preventive Medicine and Public Health. I also hold a PhD in Public Health, and a Masters in Health Care Management.

Since very early in my career, I became interested in quantitative methods, like biostatistics and epidemiologic analysis, and their application to knowledge discovery. To me, analyzing data makes me feel exactly the same as if I was working at the bench trying to discover a new link, association, something new that could eventually help to improve the health of individuals and populations.

Epidemiologic surveillance, prevention and control of diseases and adverse events, whether or not associated to the use of medicines, are aspects of my work I am comfortable with. I came to the ‘industry’ through the door of drug safety and pharmacovigilance. I have worked as a PV scientist, PV physician and, why not, PV physician scientist!

That’s why my ideal situation is working on the field of data analysis applied to pharmacovigilance and drug safety, in a broad sense.

If you want to know more about myself, please go ahead and visit my LinkedIn profile at https://www.linkedin.com/in/jrossello/

Would you like to send me an email? Please use this email address: editor@pharmacovigilanceanalytics.com

Primary Sidebar

Subscribe in a reader

Featured News / Posts

Analysis Of Textual Data May Complement Traditional Pharmacovigilance

According to a well-written systematic review on the application of natural … [Read More...] about Analysis Of Textual Data May Complement Traditional Pharmacovigilance

Machine Learning and Pharmacovigilance

Machine learning (ML) is becoming increasingly available to everyone, including … [Read More...] about Machine Learning and Pharmacovigilance

clinical trial follow-up

Post-Randomization vs On Treatment Made All the Difference

The Food and Drug Administration (FDA) recently requested withdraw of Belviq® … [Read More...] about Post-Randomization vs On Treatment Made All the Difference

Pharmacovigilance Audits/Inspections and PV Analytics!

Disclaimer: This article is written by a Safety Physician to provide … [Read More...] about Pharmacovigilance Audits/Inspections and PV Analytics!

Artificial Intelligence in pharmacovigilance? What a challenge!

Abstract Pharmaceutical industry, and more particularly pharmacovigilance, … [Read More...] about Artificial Intelligence in pharmacovigilance? What a challenge!

Some Sample Triples

Knowledge Graphs, Semantic Web and Drug Safety

Second part of: Mining PubMed for Drug Induced Acute Kidney Injury When I … [Read More...] about Knowledge Graphs, Semantic Web and Drug Safety

Review of Safety in FDA Medical Reviews

Analysis of the latest review of safety sections for new drug applications (NDAs … [Read More...] about Review of Safety in FDA Medical Reviews

Mining PubMed for Drug Induced Acute Kidney Injury

Enhancing signal detection capabilities beyond regular literature … [Read More...] about Mining PubMed for Drug Induced Acute Kidney Injury

Top 7 Predictive Model Applications in Drug Safety and Pharmacovigilance

As drug safety and pharmacovigilance organizations develop more sophisticated … [Read More...] about Top 7 Predictive Model Applications in Drug Safety and Pharmacovigilance

The Pharmacovigilance of the Future: Prospective, Proactive, and Predictive

Peter J Pitts, President of the Center for Medicine in the Public Interest, and … [Read More...] about The Pharmacovigilance of the Future: Prospective, Proactive, and Predictive

  • Disproportional Recording vs Disproportional Reporting
  • Deep Learning, Machine Learning, and Artificial Intelligence – What are the Differences?
  • How Organizations Use Social Media For Pharmacovigilance

RSS From Nature journal

  • Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
  • Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database
  • Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
  • A genetic test to predict adverse drug reactions
  • The evolving role of investigative toxicology in the pharmaceutical industry

Copyright © 2023 · News Pro on Genesis Framework · WordPress · Log in